The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2009
DOI: 10.1152/ajprenal.00254.2009
|View full text |Cite
|
Sign up to set email alerts
|

Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF-β activation

Abstract: We recently identified thrombospondin-2 (TSP-2) as an endogenous regulator of matrix remodelling and inflammation in experimental kidney disease by studying TSP-2-deficient mice. In this study, we asked whether systemic TSP-2 overexpression via thigh muscle transfection is able to ameliorate the time course of the anti-Thy1 glomerulonephritis model. After induction of anti-Thy1 nephritis, rats were transfected either with an overexpression plasmid for TSP-2 or lacZ as a control. Biopsies, urine, and blood samp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
32
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 29 publications
(34 citation statements)
references
References 37 publications
(58 reference statements)
2
32
0
Order By: Relevance
“…In accordance to our previous short term (one week) study in an acute glomerulonephritis model [15], we now demonstrate that the apparent competition of long-term TSP-2 therapy with endogenously increased TSP-1 was able to specifically inhibit TGF-β activation in CAN as assessed at the end point 7 months after application. Furthermore, we could demonstrate marked anti-inflammatory properties during CAN decreasing renal accumulation of T-cells, B-cells and macrophages by long-term TSP-2 gene therapy.…”
Section: Discussionsupporting
confidence: 91%
See 3 more Smart Citations
“…In accordance to our previous short term (one week) study in an acute glomerulonephritis model [15], we now demonstrate that the apparent competition of long-term TSP-2 therapy with endogenously increased TSP-1 was able to specifically inhibit TGF-β activation in CAN as assessed at the end point 7 months after application. Furthermore, we could demonstrate marked anti-inflammatory properties during CAN decreasing renal accumulation of T-cells, B-cells and macrophages by long-term TSP-2 gene therapy.…”
Section: Discussionsupporting
confidence: 91%
“…In healthy rat kidneys, TSP-1 as well as TSP-2 staining was absent within the glomeruli and rarely found within the tubulointerstitial compartment (data not shown, see [15]). In contrast, thirty weeks after kidney transplantation remarkable TSP-1 staining could be detected within the Bowman's capsule and to a lesser extent in the glomerular tuft of glomeruli with pronounced pathological changes (Fig.…”
Section: Resultsmentioning
confidence: 87%
See 2 more Smart Citations
“…Harvested kidneys were fixed in Zn fixative overnight and were further processed as previously described (12). Paraffin-embedded kidneys were cut into 2-m-thick sections.…”
Section: Methodsmentioning
confidence: 99%